Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Not Responding.

PHASE3CompletedINTERVENTIONAL
Enrollment

923

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Rheumatoid Arthritis
Interventions
DRUG

fostamatinib

fostamatinib 100 mg twice daily

DRUG

fostamatinib

fostamatinib 100 mg twice daily/150 mg once daily

DRUG

placebo, fostamatinib

Placebo for 24 weeks followed by fostamatinib 100 mg twice daily

Trial Locations (127)

Unknown

Research Site, Anniston

Research Site, Huntsville

Research Site, Tuscaloosa

Research Site, Tucson

Research Site, Huntington Beach

Research Site, Long Beach

Research Site, Santa Maria

Research Site, Santa Monica

Research Site, Colorado Springs

Research Site, Bridgeport

Research Site, Lewes

Research Site, Daytona Beach

Research Site, Ocala

Research Site, Atlanta

Research Site, Marietta

Research Site, Idaho Falls

Research Site, Springfield

Research Site, Wichita

Research Site, Bowling Green

Research Site, Flowood

Research Site, Florissant

Research Site, Richmond Heights

Research Site, St Louis

Research Site, Kalispell

Research Site, Albuquerque

Research Site, Albany

Research Site, Brooklyn

Research Site, Olean

Research Site, Asheville

Research Site, Greensboro

Research Site, Perrysburg

Research Site, Lake Oswego

Research Site, Erie

Research Site, Waxford

Research Site, Charleston

Research Site, Hixson

Research Site, Memphis

Research Site, Dallas

Research Site, Houston

Research Site, Mesquite

Research Site, San Antonio

Research Site, Reading

Research Site, Buenos Aires

Research Site, Ciudad Autonoma Bs As

Research Site, Córdoba

Research Site, San Juan

Research Site, Rosario

Research Site, San Miguel de Tucumán

Research Site, Caba

Research Site, Quilmes

Research Site, Camperdown

Research Site, Cairns

Research Site, Southport

Research Site, Brussels

Research Site, Yvoir

Research Site, Vitória

Research Site, Curitiba

Research Site, Recife

Research Site, São Paulo

Research Site, Rio de Janeiro

Research Site, Plovdiv

Research Site, Sevlievo

Research Site, Sofia

Research Site, Veliko Tarnovo

Research Site, Osorno

Research Site, Santiago

Research Site, Pärnu

Research Site, Tallinn

Research Site, Tartu

Research Site, Orléans

Research Site, Paris

Research Site, Balatonfüred

Research Site, Békéscsaba

Research Site, Budapest

Research Site, Debrecen

Research Site, Makó

Research Site, Sopron

Research Site, Szentes

Research Site, Zalaegerszeg-pozva

Research Site, Secunderabad

Research Site, Visakhapatnam

Research Site, Ahmedabad

Research Site, Bangalore

Research Site, Mangalore

Research Site, Udupi

Research Site, Nagpur

Research Site, Lucknow

Research Site, Hyderabad

Research Site, Kolkata

Research Site, Chihuahua City

Research Site, Saltillo

Research Site, Guadalajara

Research Site, Mexico City

Research Site, San Luis Potosi

Research Site, Monterrey

Research Site, Obrergon

Research Site, Mexicali

Research Site, Arequipa

Research Site, Lima

Research Site, Pueblo Libre

Research Site, Bytom

Research Site, Chełm Śląski

Research Site, Grodzisk Mazowiecki

Research Site, Katowice

Research Site, Krakow

Research Site, Warsaw

Research Site, Wroclaw

Research Site, Żyrardów

Research Site, Bratislava

Research Site, Žilina

Research Site, Poprad

Research Site, Rimavská Sobota

Research Site, Donetsk

Research Site, Ivano-Frankivsk

Research Site, Kharkiv

Research Site, Kiev

Research Site, Kyiv

Research Site, Lviv

Research Site, Odesa

Research Site, Vinnytsia

Research Site, Zaporyzhzhya

Research Site, Warrington

Research Site, Christchurch

Research Site, Ipswich

Research Site, London

Research Site, Metropolitan Borough of Wirral

Research Site, Westcliff-on-the Sea

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY

NCT01197521 - Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Not Responding. | Biotech Hunter | Biotech Hunter